MPSYF News and Press, Morphosys Ag Ord From 05/12/20

MorphoSys AG (MPSYF) Q1 2020 Earnings Conference Call May 7, 2020 8:00 AM ET Company Participants Julia Neugebauer - Director of IR Jean Kress - Chairman of Management Board, MD & CEO Jens Holstein - CFO & Member of the Management Board Malte Peters - Chief Research &a...

The following slide deck was published by MorphoSys AG in conjunction with their 2020 Q1 earnings Read more ...

MorphoSys AG ( OTCPK:MPSYF ): Q1 GAAP EPS of €6.11. More news on: MorphoSys AG, MorphoSys AG ADR, Earnings news and commentary, Healthcare stocks news, Read more ...

Source : ClearBridge Investments Editor's Note : The summary bullets for this article were chosen by Read more ...

MorphoSys AG (MPSYF) Q4 2019 Earnings Conference Call March 19, 2020 9:00 a.m. ET Company Participants Julia Neugebauer - Director of Corporate Communications and Investor Relations Jean-Paul Kress - Chief Executive Officer Jens Holstein - Chief Financial Officer Malte Peters -...

The following slide deck was published by MorphoSys AG in conjunction with their 2019 Q4 earnings Read more ...

Introduction Now that we are in the back half of Q1, I have run out of time to do a full article on every biotech I own, have sold out of, or in other ways have discussed in the past two or so years on Seeking Alpha . So, I would like to provide commentary on several of these stocks, and al...

The core franchises of Vertex Pharmaceuticals (NASDAQ: VRTX) and Incyte (NASDAQ: INCY) continue to generate hefty sales, enabling the companies to invest heavily in exciting research and development programs. While Vertex's $63 billion valuation towers over Incyte's $17 billion market ca...

Morphosys Ag (MPSYF) Q3 2019 Results Earnings Conference Call October 30, 2019, 09:00 AM ET Company Participants Sarah Fakih - Vice President/Head of Corporate Communications & Investor Relations Jean-Paul Kress - Chief Executive Officer Jens Holstein - Chief Financial Office...

The following slide deck was published by MorphoSys AG in conjunction with their 2019 Q3 earnings Read more ...